Type 2 diabetes mellitus (T2DM) is a serious, chronic, and progressive disease
that is rapidly increasing in prevalence. The disease now affects >10% of adults ...
Drugs. 2006;66(1):85-109. Pioglitazone: a review of its use in type 2 diabetes
mellitus. Waugh J(1), Keating GM, Plosker GL, Easthope S, Robinson DM.
Oct 18, 2006 ... Pioglitazone for type 2 diabetes mellitus. Diseases of the heart and blood vessels
account for approximately 70% of all mortality in people with ...
Actos (pioglitazone) is a Type 2 diabetes medication that regulates blood sugar
levels in the body. Learn about its uses, interactions and side effects.
Aug 17, 2012 ... The U.S. Food and Drug Administration today approved the first generic version
of Actos (pioglitazone hydrochloride) tablets. Along with diet ...
Jun 17, 2016 ... But this isn't the first time pioglitazone has been shown to reduce the risk of type 2
diabetes, he stressed. In 2011, the Actos Now for Prevention ...
In clinical trials in patients with type 2 diabetes mellitus, pioglitazone as
monotherapy, or in combination with metformin, repaglinide, insulin or a
Pioglitazone alters monocyte populations and stimulates recent thymic emigrants
in the BBDZR/Wor type 2 diabetes rat model. Bradley T. Gao,; Ryan P. Lee, ...
Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Pioglitazone for
type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2006, ...
Dec 16, 2015 ... Benefit/Risk Profile Remains Positive for Pioglitazone as an Important Treatment
Option for Type 2 Diabetes. Takeda Comments on Letters to ...